Çakir, E. Et Al. 2023. Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment. European Review for Medical and Pharmacological Sciences , vol.27, no.9 , 4309-4315.

Çakir, E., Saydan, D., Gülbagci, B., Özen, M., Uǧurlu, İ., Demirci, A., ... Bilir, F.(2023). Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment. European Review for Medical and Pharmacological Sciences , vol.27, no.9, 4309-4315.

Çakir, E. Et Al. "Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment," European Review for Medical and Pharmacological Sciences , vol.27, no.9, 4309-4315, 2023

Çakir, E. Et Al. "Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment." European Review for Medical and Pharmacological Sciences , vol.27, no.9, pp.4309-4315, 2023

Çakir, E. Et Al. (2023) . "Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment." European Review for Medical and Pharmacological Sciences , vol.27, no.9, pp.4309-4315.

@article{article, author={E. Çakir Et Al. }, title={Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment}, journal={European Review for Medical and Pharmacological Sciences}, year=2023, pages={4309-4315} }